Discover Our Latest News

AACR 2026 Data Show Multi-Biomarker MCED Approach Improves Early Cancer Detection

FDA Grants Breakthrough Designation to First Urine-Based Multi-Cancer Early Detection Test

Daraxonrasib Doubles Overall Survival in Previously Treated Metastatic Pancreatic Cancer

AI Nodule Detection Helps Sarasota Memorial Reach 75% Early Lung Cancer Diagnosis

Illumina Launch 100 K Genome Effort to Advance Cancer and Rare Disease Research

Zenocutuzumab Gains NCCN Support as FDA Review Advances in Cholangiocarcinoma

Phase 2 Data Position Trastuzumab Pamirtecan as a Promising Option in Endometrial Cancer

FDA Grants Priority Review to Ifinatamab Deruxtecan in Pretreated ES-SC Lung Cancer

Mocertatug Rezetecan Shows Strong Responses in Ovarian and Endometrial Cancers

MD Anderson Study Identifies DPY30 as Therapeutic Target in Pancreatic Cancer

Blocking DHODH Helps Triple Combination Overcome Resistance in Lung Cancer

New Strategy Blocks NMD, Unmasks Hidden Tumor Antigens, and Boosts Immunotherapy

Neladalkib Reaches FDA Review for TKI-Pretreated ALK+ Non-Small Cell Lung Cancer

New B7-H3 Radio-Theranostic Promises to Broaden Targeted Radiation Across Solid Tumors

FDA Grants Breakthrough Status to WU-CART-007 for T-Cell Leukemias and Lymphomas

Immunotherapy Boosts Chemo Cutting Recurrence Risk by 50% in Colon Cancer

New IHC Biomarker Test Predicts Which Gastric Cancer Patients Benefit from Immunotherapy

Nonviral Gene Delivery Platform Offers Promise for Cancer Treatment and Cell Therapy

AI Predicts Chemotherapy Benefit in Breast Cancer Using Routine Pathology Slides

FDA Approves Agilent’s PD-L1 Test to Guide KEYTRUDA Use in Esophageal and GEJ Carcinoma

Light-Activated Copper Nanoparticles Trigger Cuproptosis in Drug-Resistant Cancer Cells

New Protein Modification Linked to IDH-Mutant Cancers Opens Therapeutic Possibilities

BioNTech Showcases Promising Bispecific and ADC Data in Lung Cancer at ELCC 2026

Magnetic Nanoparticle-Guided Hyperthermia Opens a New Path for Advanced Solid Tumors

Sunvozertinib Outperforms Chemo in First-Line EGFR Exon 20 Insertion NSC Lung Cancer

TG Therapeutics Secures $500M to Advance BRIUMVI in Relapsing Multiple Sclerosis

TALAPRO-3 Trial Supports Early Use of Talazoparib in HRR+ mCS Prostate Cancer

FDA Approves Nivolumab-AVD as First Immunotherapy Combination for Hodgkin Lymphoma

Abenacianine Enters Phase 3 to Enhance Real-Time Tumor Detection in Lung Surgery

CellCarta Secures Global Exclusivity for Aspyre Lung to Advance Lung Cancer Testing